Particle.news

Download on the App Store

Researchers Advance Dual Cooling and Antioxidant Method to Prevent Chemo Hair Loss, Clinical Trials Imminent

Published in Frontiers of Pharmacology, the method combines an 18°C-optimized cold cap with a resveratrol-based lotion, set to enter clinical trials using the Paxman device.

Image
Image
Image

Overview

  • Ex vivo tests demonstrated that pairing optimized scalp cooling at 18°C with a topical antioxidant lotion fully protects hair follicles from chemotherapy damage.
  • Sheffield Hallam University researchers determined that cooling to 18°C is essential for follicle preservation, while 26°C proved insufficient.
  • The antioxidant formulation, containing resveratrol and N-acetylcysteine, boosts the protective effect of cooling by countering oxidative stress.
  • Paxman’s adapted scalp cooling system administers the combined therapy in half-hour pre-treatment, during chemotherapy, and up to 90 minutes post-treatment sessions.
  • Following the July 9 publication of these lab results, the team is finalizing lotion formulations and coordinating clinical trials to assess real-world efficacy.